These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9632841)

  • 1. Administration of a glucocorticoid with depot effect counteracts the stimulating effect of growth hormone on cancellous and cortical bone of the vertebral body in rats.
    Ortoft G; Oxlund H; Andreassen TT
    Calcif Tissue Int; 1998 Jul; 63(1):14-21. PubMed ID: 9632841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.
    Ortoft G; Oxlund H
    Bone; 1996 Jun; 18(6):581-90. PubMed ID: 8806000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect.
    Ortoft G; Brüel A; Andreassen TT; Oxlund H
    Bone; 1995 Dec; 17(6):543-48. PubMed ID: 8835308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.
    Ortoft G; Andreassen TT; Oxlund H
    Bone; 2005 Jan; 36(1):123-33. PubMed ID: 15664010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats.
    Andreassen TT; Melsen F; Oxlund H
    J Bone Miner Res; 1996 Aug; 11(8):1094-102. PubMed ID: 8854245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spine bone mineral density and vertebral body height are altered by alcohol consumption in growing male and female rats.
    Wezeman FH; Juknelis D; Frost N; Callaci JJ
    Alcohol; 2003; 31(1-2):87-92. PubMed ID: 14615015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats.
    Ejersted C; Andreassen TT; Hauge EM; Melsen F; Oxlund H
    Bone; 1995 Dec; 17(6):507-11. PubMed ID: 8835302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid treatment or food deprivation counteract the stimulating effect of growth hormone on rat cortical bone strength.
    Ortoft G; Oxlund H; Jørgensen PH; Andreassen TT
    Acta Paediatr; 1992 Nov; 81(11):912-7. PubMed ID: 1281699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin given perorally to adult rats increases cancellous bone mass and compressive strength.
    Oxlund H; Dalstra M; Andreassen TT
    Calcif Tissue Int; 2001 Nov; 69(5):299-304. PubMed ID: 11768201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS; Schmidt IU; Evans GL; Turner RT
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
    J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effects of growth hormone, exercise and food restriction on cancellous bone in different bone sites in middle-aged female rats.
    Banu J; Orhii PB; Okafor MC; Wang L; Kalu DN
    Mech Ageing Dev; 2001 Jun; 122(8):849-64. PubMed ID: 11337013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep.
    Schorlemmer S; Ignatius A; Claes L; Augat P
    Bone; 2005 Oct; 37(4):491-6. PubMed ID: 16046208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: a model for the effects of polycystic ovarian disease on the skeleton?
    Lundon KM; Jayo MJ; Register TC; Dumitriu M; Grynpas MD
    Osteoporos Int; 2000; 11(9):778-89. PubMed ID: 11210841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
    Jiang Y; Zhao JJ; Mitlak BH; Wang O; Genant HK; Eriksen EF
    J Bone Miner Res; 2003 Nov; 18(11):1932-41. PubMed ID: 14606504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal changes in rats bearing mammosomatotrophic pituitary tumors: a model of acromegaly with gonadal dysfunction.
    Morimoto I; Kai K; Okada Y; Okimoto N; Uriu K; Akino K; Yamashita S; Nakamura T; Eto S
    Bone; 2000 Mar; 26(3):255-61. PubMed ID: 10709998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.